5HU9

Crystal structure of ABL1 in complex with CHMFL-074

5HU9 の概要

• エントリーDOI: 10.2210/pdb5hu9/pdb
• 分子名称: Tyrosine-protein kinase ABL1, 4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[1-(pyridin-3-ylcarbonyl)piperidin-4-yl]oxy}phenyl)-3-(trifluoromethyl)benzamide, 1,2-ETHANEDIOL, ... (5 entities in total)
• 機能のキーワード: abl, bcr-abl, chmfl-074, transferase-transferase inhibitor complex, transferase/transferase inhibitor
• 由来する生物種: Homo sapiens (Human)
• 細胞内の位置: Cytoplasm, cytoskeleton. Isoform IB: Nucleus membrane; Lipid-anchor: P00519
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 33954.19

構造登録者

Kong, L.L.,Yun, C.H. (登録日: 2016-01-27, 公開日: 2016-07-13, 最終更新日: 2023-11-08)

• 主引用文献: Liu, F.,Wang, B.,Wang, Q.,Qi, Z.,Chen, C.,Kong, L.L.,Chen, J.Y.,Liu, X.,Wang, A.,Hu, C.,Wang, W.,Wang, H.,Wu, F.,Ruan, Y.,Qi, S.,Liu, J.,Zou, F.,Hu, Z.,Wang, W.,Wang, L.,Zhang, S.,Yun, C.H.,Zhai, Z.,Liu, J.,Liu, Q.; Discovery and characterization of a novel potent type II native and mutant BCR-ABL inhibitor (CHMFL-074) for Chronic Myeloid Leukemia (CML); Oncotarget, 7:45562-45574, 2016; PubMed: 27322145; DOI: 10.18632/oncotarget.10037

実験手法

X-RAY DIFFRACTION (1.529 Å)